#Global Western Blotting Market Research Report

[tamanna31]

Botulinum Toxin Market Segmentation, Parameters and Prospects 2024 to 2030 Industry Research Report

Botulinum Toxin Industry Overview

The global botulinum toxin market size was valued at USD 11.1 billion in 2023 and is expected to grow at a compound annual growth rate (CAGR) of 9.8% from 2024 to 2030. Botulinum toxin is a protein and neurotoxin produced by the bacterium clostridium botulinum. The toxin is a selective blocker of acetylcholine released from nerves, which blocks neural transmission from the nerves when injected into muscle. Botulinum toxin is one of the most exceptional substances encountered in medicine and science. The adoption of botulinum toxin in cosmetology has grown rapidly over the decade, and at present it is one of the most common and widely performed aesthetic procedures in the world. The increasing concern for aesthetic features in developed and developing regions has led to an increase in the number of cosmetic procedures.

Gather more insights about the market drivers, restrains and growth of the Botulinum Toxin Market

The availability of a variety of botulinum toxin products such as botox, xeomin, dysport, and others will accelerate the market growth. The increasing usage of botulinum toxin injection in several aesthetic procedures including the treatment of glabellar lines, chemical browlift, forehead lines, and others is expected to boost the botulinum toxin industry growth over the coming years. Presently, a few products of botulinum toxin - Type-A and only one product of Type-B (Myobloc) are commercially available in the market.

However, rising investment in R&D programs by major manufactures to explore the therapeutic use of botulinum toxin is building opportunities for the expansion of its therapeutic application area in the near future. A shift from invasive to minimally invasive procedures is expected to fuel the market growth over the forecast period. For instance, according to ISAPS, 17,598,888 noninvasive procedures were performed globally in 2021, out of which 5,355,604 were performed in the U.S. A large number of people are opting for permanent procedures, such as fillers, fat grafting, and lip advancement.

Minimally invasive procedures offer advantages such as smaller incisions, shorter hospital stays, quick outpatient services, rapid wound healing, lesser pain, and lower risk of complications than invasive surgeries. Thus, the demand for botulinum toxin is expected to increase over the forecast period. Moreover, many dermatologists believe that COVID-19 may act as a springboard that will drastically increase patient footfall post-pandemic.

According to a survey conducted on 1,000 American women in 2020 by American Society of Plastic Surgeons, 11% of participants indicated that they are more inclined to opt for minimally invasive procedures post-pandemic than pre-COVID-19. Even during the pandemic, Botox and soft tissue fillers remained the most popular minimally invasive procedures in the U.S.

Browse through Grand View Research's Medical Devices Industry Research Reports.

• The global bronchoscopes market size was valued at USD 1.14 billion in 2023 and is projected to grow at a CAGR of 11.4% from 2024 to 2030. The rising incidences of respiratory disorders and growing awareness about early diagnosis are driving demand for bronchoscopes.

• The global western blotting market size was valued at USD 986.2 million in 2023 and is projected to grow at a CAGR of 6.1% from 2024 to 2030. The rising rate of brain disorders, research initiatives in the biotech and pharma sectors, and funding by the pharmaceutical and biotechnology agencies drive market growth.

Botulinum Toxin Market Segmentation

Grand View Research has segmented the global botulinum toxin market report based on product type, application, end-use, and region:

Botulinum Toxin Product Type Outlook (Revenue, USD Billion, 2018 - 2030) • Type A o Botox o Dysport o Xeomin o Others • Type B

Botulinum Toxin Application Outlook (Revenue, USD Billion, 2018 - 2030) • Therapeutic o Chronic Migraine o Overactive Bladder o Cervical Dystonia o Spasticity o Others • Aesthetic o Glabellar Lines o Crow’s Feet o Forehead Lines o Others

Botulinum Toxin End-use Outlook (Revenue, USD Billion, 2018 - 2030) • Hospitals • Dermatology Clinics • Cosmetic Centers and Medspas

Botulinum Toxin Regional Outlook (Revenue, USD Billion, 2018 - 2030) • North America o US o Canada • Europe o UK o Germany o France o Italy o Spain o Denmark o Sweden o Norway • Asia Pacific o India o Japan o China o South Korea o Australia o Thailand • Latin America o Brazil o Mexico o Argentina • Middle East & Africa o South Africa o Saudi Arabia o UAE o Kuwait

Order a free sample PDF of the Botulinum Toxin Market Intelligence Study, published by Grand View Research.

Key Companies profiled: • Ipsen Group • Allergen, Inc. • Metabiologics • Merz Pharma • US Worldmeds • Evolus • Galderma • Lanzhou Institute of Biological Products

[industrynewsupdates]

Blood Screening Market Analysis, Opportunities And Forecast Report 2024-2030

The global blood screening market size was valued at USD 2.76 billion in 2022 and is anticipated to grow at a compound annual growth rate (CAGR) of 11.7% from 2023 to 2030. 

Blood screening is a process in which donated blood is screened for infectious diseases such as HBV, HCV, HIV1, and HIV2. The high growth of this market is attributed to rising blood donations, an increase in the incidence of infectious diseases, and government initiatives. According to World Health Organization (WHO), 118.54 million blood donations are collected yearly. In the U.S., 6.8 million individuals donate blood annually, and 13.6 million units of red blood cells and whole blood are collected annually.

Gather more insights about the market drivers, restrains and growth of the Blood Screening Market

The market is primarily driven by the rise in the rate of disorders such as HIV, diphtheria, measles and chronic diseases such as hemophilia, cancer, and other blood-related disorders. Blood-based diagnostics are used to diagnose a wide range of diseases, including infectious diseases, cancer, and cardiovascular diseases. Serology tests detect the presence of antibodies to a specific disease-causing organism. These tests diagnose various infectious diseases, including HIV, hepatitis B, and syphilis. Molecular tests detect the presence of DNA or RNA from a specific disease-causing organism. These tests are more sensitive than serology tests and can be used to diagnose diseases at an earlier stage. Biochemical tests measure the levels of certain substances in the blood. These tests can diagnose a wide range of diseases, including diabetes, kidney disease, and liver disease.

The COVID-19 pandemic had a significant impact on the market. Although respiratory droplets are the primary means of COVID-19 virus transmission, research has shown that viral RNA may be discovered in blood samples, supporting blood screening for COVID-19 identification, hence driving the market significantly. 

Blood Screening Market Segmentation

Grand View Research has segmented the global blood screening market based on technology, product, and region:

Technology Outlook (Revenue, USD Million, 2018 - 2030)

• Nucleic Acid Amplification Test (NAT)

• ELISA

• Chemiluminescence Immunoassay (CLIA) and Enzyme Immunoassay (EIA)

• Next Generation Sequencing

• Western Blotting

Product Outlook (Revenue, USD Million, 2018 - 2030)

• Reagent

• Instrument

Regional Outlook (Revenue, USD Million, 2018 - 2030)

• North America

o U.S.

o Canada

• Europe

o UK

o Germany

o France

o Italy

o Spain

o Sweden

o Norway

o Denmark

• Asia Pacific

o Japan

o China

o India

o Australia

o Thailand

o South Korea

• Latin America

o Brazil

o Mexico

o Argentina

• Middle East and Africa

o Saudi Arabia

o South Africa

o UAE

o Kuwait

Browse through Grand View Research's Medical Devices Industry Research Reports.

• The global embolic protection devices market size was valued at USD 612.9 million in 2023 and is projected to grow at a CAGR of 8.7% from 2024 to 2030. 

• The global covered stent market size was estimated at USD 1.13 billion in 2023 and is projected to grow at a CAGR of 4.1% from 2024 to 2030. 

Key Companies & Market Share Insights

Product launches, approvals, strategic acquisitions, and innovations are just a few of the important business strategies used by market participants to maintain and grow their global reach.

For instance, in March 2023, Abbott received U.S Food and Drug Administration (FDA) clearance for a laboratory traumatic brain injury blood test, the first commercially available lab-based test for the assessment of mild traumatic brain injuries (TBIs), commonly referred to as concussions, which will be made widely available to hospitals across the U.S. This test, which is powered by Abbott’s Alinity i laboratory tool, will enable clinicians to evaluate individuals with mild traumatic brain injuries in a timely manner.

Furthermore, in May 2023, Siemens Healthcare introduced Atellica HEMA 570 and 580 next-generation hematology analyzers, which have user-friendly interfaces and can be connected to multiple analyzers to remove workflow barriers and provide high throughput time.

Key Blood Screening Companies:

• Abbott

• Danaher Corporation (Beckman Coulter)

• Becton Dickinson and Company

• Bio-Rad Laboratories, Inc.

• Hoffman-La Roche Ltd.

• Grifols, S.A.

• Ortho-Clinical Diagnostics, Inc.

• Siemens Healthcare GmbH

• Thermo Fisher Scientific, Inc.

• SOFINA s.a (Biomerieux)

Order a free sample PDF of the Blood Screening Market Intelligence Study, published by Grand View Research. 

[researchinsights]

The global western blotting market size was valued at USD 983.8 million in 2023 and is poised to grow at a significant CAGR of 7.2% during the forecast period 2024-30. It also includes market size and projection estimations for each of the five major regions from 2024 to 2030. The research report includes historical data, trending features, and market growth estimates for the future.

[bhushans]

Global Focus on Improved Outcomes: Global Neuro Immunoassay Market

The global neuro immunoassay market is poised for remarkable expansion, with projections indicating a surge to USD 5,303.1 million by 2033, according to recent market analysis. This forecast marks a substantial increase from its 2023 valuation of USD 2,616.1 million, reflecting a robust Compound Annual Growth Rate (CAGR) of 7.3% during the forecast period.

Neuro immunoassay, a vital segment within the healthcare industry, plays a pivotal role in diagnosing and monitoring neurological disorders and autoimmune diseases. With advancements in technology and an evolving understanding of these conditions, the demand for accurate and efficient diagnostic tools is on the rise. Neuro immunoassay techniques offer a precise and reliable means of detecting biomarkers associated with various neurological and autoimmune conditions, driving their adoption across clinical settings worldwide.

Initiate In-Depth Research With Your Sample: https://www.futuremarketinsights.com/reports/sample/rep-gb-4293

The projected growth of the neuro immunoassay market underscores the increasing prevalence of neurological disorders and autoimmune diseases globally. As populations age and lifestyles evolve, the incidence of these conditions continues to escalate, necessitating advanced diagnostic solutions for timely intervention and management.

Key Takeaways:

The global neuro immunoassay market is expected to reach a value of US$5,303.1 million by 2033, reflecting a significant increase from US$2,616.1 million in 2023.

This growth is projected at a healthy compound annual growth rate (CAGR) of 7.3% during the forecast period.

The surge in demand is attributed to the crucial role of immunoassays in various applications like biopharmaceutical analysis, clinical diagnostics, and early disease detection.

Key Segments of the Neuro Immunoassay Market

By Technology:

Radioimmunoassays (RIA)

Polymerase Chain Reaction (PCR)

ELISA

Western Blot

Rapid Tests

ELISPOT

By Product Type:

Reagents and Kits

Analysers

By Application:

Alzheimer’s Disease

Parkinson’s Disease

Huntington’s Disease

Amyotrophic Lateral Sclerosis (ALS)

Spinal Muscular Atrophy (SMA)

By End User:

Hospitals

Clinics

Academic Organizations

Biopharmaceutical Companies

Pharmaceutical Companies

Others

By Region:

North America

Latin America

Asia Pacific

Middle East and Africa

Europe

[industryforecastnews]

Research Antibodies Market Size, Share & Growth Report, 2030

Research Antibodies Market Growth & Trends

The global research antibodies market size is expected to reach USD 2.21 billion by 2030, expanding at a CAGR of 4.76% from 2024 to 2030, according to a new report by Grand View Research, Inc. Factors driving the market include a rise in R&D activities undertaken by biopharmaceutical and biotechnology companies and increase in support from government authorities. Furthermore, expansion in the scope of neurobiology and stem cell research and the availability of technologically advanced antibody production methods are expected to propel market growth.

An increase in the number of collaborative initiatives undertaken by research institutes and various public and private entities for the promotion of cell-based research is fueling market growth. The trend is more prominent in established markets, such as North America, that have an established scientific infrastructure. For instance, in March 2020, the Canadian government invested around USD 4.3 million in funds towards the Centre for Commercialization of Regenerative Medicine, which is involved in carrying out scientific studies based on cell regeneration. Moreover, in April 2021, the government announced an investment of USD 45 million over 3 years in Stem Cell Network to develop information, therapies, and technologies to benefit individuals living with chronic and severe illnesses such as COVID-19 and assess its long-term impact. Such initiatives are expected to encourage further adoption of antibody activities and enhance the growth prospects for the market.

The COVID-19 outbreak has created lucrative growth opportunities for the market. Several leading pharmaceutical companies are investing significantly in R&D for creating effective testing tools and increasing scientific understanding of the disease. The need for research antibodies has greatly increased as a result of these intense R&D operations for the development of novel vaccination and therapy techniques. Additionally, a number of public and commercial entities are making significant efforts to fund the development of COVID-19 vaccines and therapeutics. For instance, in April 2020, Emergent BioSolutions, a biopharmaceutical company, received USD 14.5 million from the federal government to work on an antibody therapy study for COVID-19.

Request a free sample copy or view report summary: https://www.grandviewresearch.com/industry-analysis/research-antibodies-market

Research Antibodies Market Report Highlights

In 2023, the primary product segment held the largest revenue share due to the higher specificity and direct detection capabilities offered by the antibodies

By type, monoclonal antibodies captured a substantial share in 2023 due to the increase in COVID-19-related research activities involving the use of such antibodies

The western blotting technology segment held a dominant share in 2023 because of the increasing investments in R&D activities by several biotechnology and pharmaceutical companies and the rapidly growing applications of antibodies in western blots created for proteomic studies

By end-use, academic and research institutions held the largest share in 2023 due to a rise in funding opportunities and growth in the number of scientific institutions involved in life sciences

In 2023, North America accounted for the largest share of over 39.15% due to the widespread presence of life sciences research institutions and numerous biotechnology and biopharmaceutical manufacturers inthe region

Research Antibodies Market Segmentation

Grand View Research has segmented the global research antibodies market on the basis of product, type, technology, source, application, end-use, and region:

Research Antibodies Product Outlook (Revenue, USD Billion, 2018 - 2030)

Primary Antibodies

Secondary Antibodies

Research Antibodies Type Outlook (Revenue, USD Billion, 2018 - 2030)

Monoclonal Antibodies

Polyclonal Antibodies

Research Antibodies Technology Outlook (Revenue, USD Billion, 2018 - 2030)

Immunohistochemistry

Immunofluorescence

Western Blotting

Flow Cytometry

Immunoprecipitation

ELISA

Others

Research Antibodies Source Outlook (Revenue, USD Billion, 2018 - 2030)

Mouse

Rabbit

Goat

Others

Research Antibodies Application Outlook (Revenue, USD Billion, 2018 - 2030)

Infectious Diseases

Immunology

Oncology

Stem Cells

Neurobiology

Others

Research Antibodies End Use Outlook (Revenue, USD Billion, 2018 - 2030)

Academic & Research Institutes

Contract Research Organizations

Pharmaceutical & Biotechnology Companies

Research Antibodies Regional Outlook (Revenue, USD Billion, 2018 - 2030)

North America

S.

Canada

Europe

Germany

UK

France

Italy

Spain

Denmark

Sweden

Norway

Asia Pacific

Japan

China

India

Australia

Thailand

South Korea

Singapore

Latin America

Brazil

Mexico

Argentina

Middle East & Africa

South Africa

Saudi Arabia

UAE

Kuwait

List of Key Players in Research Antibodies Market

Abcam Plc.

Merck KGaA

Thermo Fisher Scientific, Inc.

Cell Signalling Technology, Inc.

Santa Cruz Biotechnology Inc.

PerkinElmer, Inc.

Becton, Dickinson and Company

Bio-Techne Corporation

Proteintech Group, Inc.

Jackson ImmunoResearch Inc.

Browse Full Report: https://www.grandviewresearch.com/industry-analysis/research-antibodies-market

[farhan7212]

Protein Purification and Isolation Market trends, and forecasts from 2024 to 2034

The Protein Purification and Isolation market report offered by Reports Intellect is meant to serve as a helpful means to evaluate the market together with an exhaustive scrutiny and crystal-clear statistics linked to this market. The report consists of the drivers and restraints of the Protein Purification and Isolation Market accompanied by their impact on the demand over the forecast period. Additionally, the report includes the study of prospects available in the market on a global level. With tables and figures helping evaluate the Global Protein Purification and Isolation market, this research offers key statistics on the state of the industry and is a beneficial source of guidance and direction for companies and entities interested in the market. This report comes along with an additional Excel data-sheet suite taking quantitative data from all numeric forecasts offered in the study.

Get Sample PDF Brochure @ https://www.reportsintellect.com/sample-request/2910932

Key players offered in the market: Thermo Fisher Scientific Merck KGaA Qiagen N.V. Agilent Technologies Bio-Rad Laboratories GE Healthcare Bio-Sciences Sigma-Aldrich Corporation Promega Corporation Abcam plc

Additionally, it takes account of the prominent players of the Protein Purification and Isolation market with insights including market share, product specifications, key strategies, contact details, and company profiles. Similarly, the report involves the market computed CAGR of the market created on previous records regarding the market and existing market trends accompanied by future developments. It also divulges the future impact of enforcing regulations and policies on the expansion of the Protein Purification and Isolation Market.

Scope and Segmentation of the Protein Purification and Isolation Market

The estimates for all segments including type and application/end-user have been provided on a regional basis for the forecast period from 2024 to 2034. We have applied a mix of bottom-up and top-down methods for market estimation, analyzing the crucial regional markets, dynamics, and trends for numerous applications. Moreover, the fastest & slowest growing market segments are pointed out in the study to give out significant insights into each core element of the market.

Protein Purification and Isolation Market Type Coverage: - Ultrafiltration Precipitation Chromatography Electrophoresis Western Blotting

Protein Purification and Isolation Market Application Coverage: - Drug Screening Biomarker Discovery Protein-protein Interaction Studies Diagnostics

Regional Analysis:

North America Country (United States, Canada) South America Asia Country (China, Japan, India, Korea) Europe Country (Germany, UK, France, Italy) Other Countries (Middle East, Africa, GCC)

Also, Get an updated forecast from 2024 to 2034.

Discount PDF Brochure @ https://www.reportsintellect.com/discount-request/2910932

The comprehensive report provides:

· Complete assessment of all opportunities and threats in the global market.

· Protein Purification and Isolation Market recent advancements and major events.

· A thorough study of business policies for the growth of the Protein Purification and Isolation Market leading players.

· Concluding study about the growth plot of Protein Purification and Isolation Market for upcoming years.

· Detailed understanding of Protein Purification and Isolation Market particular drivers, restraints, and major micro markets.

· Favorable impression inside vital technological and market latest trends hitting the Protein Purification and Isolation Market.

Reasons to Purchase Protein Purification and Isolation Market Research Report

· Develop a competitive approach based on the competitive landscape

· Build business strategy by identifying the high growth and attractive Protein Purification and Isolation market classifications

· Identify potential business partners, gaining targets and business buyers

· Design financial investment policies based on estimated high potential segments

· Prepare management and tactical presentations using the Protein Purification and Isolation market data

· Plan for new product promotion and portfolio in advance

Covid-19 Impact Analysis: Our research analysts are highly focused on the Protein Purification and Isolation Market covid-19 impact analysis. A whole chapter is dedicated to the covid-19 outbreak so that our clients get whole and sole details about the market ups & downs. With the help of our report the clients will get vast statistics as to when and where should they invest in the industry.

Contact Us: sales@reportsintellect.com Phone No: + 1-706-996-2486 US Address: 225 Peachtree Street NE, Suite 400, Atlanta, GA 30303

[alicesara611]

The Rising Demand for Non-Radioactive Nucleic Acid Labeling Products: A 2030 Outlook

The global non-radioactive nucleic acid labeling product market is expected to grow from US$ 1.5 billion in 2023 to US$ 2.5 billion by 2030, at a CAGR of 7.5% during the forecast period. The growth of the market is attributed to the increasing demand for non-radioactive nucleic acid labeling products in various applications, such as molecular biology, genomics, and proteomics.

Non-radioactive nucleic acid labeling products offer several advantages over radioactive labeling products, such as safety, ease of use, and cost-effectiveness. Radioactive labeling products are hazardous to work with and require specialized training and equipment. Non-radioactive labeling products, on the other hand, are safe to use and do not require any special training or equipment. Additionally, non-radioactive labeling products are typically less expensive than radioactive labeling products.

Request A Sample Copy of This Research Report! https://bit.ly/45QNbgh

Non-radioactive nucleic acid labeling products are a safe and effective alternative to radioactive labeling products. They are used to label nucleic acids, such as DNA and RNA, with a variety of different labels, such as fluorescent dyes, haptens, and enzymes. These labeled nucleic acids can then be used in a variety of different applications, such as in situ hybridization (ISH), Southern blotting, Northern blotting, and Western blotting.

Key Market Trends:

The increasing adoption of non-radioactive labeling techniques in molecular biology and biotechnology research is the key market trend driving the growth of the non-radioactive nucleic acid labeling product market. Non-radioactive labeling techniques are safer, more convenient, and more sensitive than traditional radioactive labeling techniques.

Another key market trend is the growing demand for non-radioactive nucleic acid labeling products in the pharmaceutical industry. Pharmaceutical companies are using non-radioactive labeling products to develop new drugs and therapies.

Key Takeaways:

The global non-radioactive nucleic acid labeling product market is expected to grow from US$ 1.5 billion in 2023 to US$ 2.5 billion by 2030, at a CAGR of 7.5%

The growth of the market is attributed to the increasing demand for non-radioactive nucleic acid labeling products in various life science applications, such as DNA sequencing, PCR, and hybridization.

Other factors driving the market growth include the rising prevalence of infectious diseases, the growing demand for personalized medicine, and the increasing investment in life science research.

Regional Outlook:

North America is expected to be the largest market in terms of revenue, accounting for over 35% of the global market share in 2023.

The growth of the market in this region is attributed to the increasing demand for non-radioactive nucleic acid labeling products in the pharmaceutical and biotechnology industries.

Europe is expected to be the second-largest market, followed by Asia Pacific.

The growth of the market in Asia Pacific is attributed to the increasing investment in life science research and the growing demand for personalized medicine in this region.

Key Players:

Some of the key players in the global non-radioactive nucleic acid labeling product market include:

Thermo Fisher Scientific

PerkinElmer

Roche Diagnostics

GE Healthcare

Illumina

Agilent Technologies

Qiagen

Merck KGaA

Bio Rad Laboratories

Invitrogen

Promega

Segmentation:

By Product Type:

Enzymes

Probes

Kits

Others

By Application:

DNA Sequencing

PCR

Hybridization

Other Applications

By End User:

Pharmaceutical and Biotechnology Companies

Academic and Research Institutes

Hospitals and Diagnostic Centers

Other End Users

[healthcareanna]

Autoimmune Disease Treatment Market Report Insights, Global Strategies & Growth Factors

Autoimmune Disease Treatment Market Overview

Market Research Future (MRFR)’s latest assessment reveals that the global autoimmune disease treatment market share is expected to thrive at Steady CAGR during the forecast period. The market signifies massive unmet needs for diagnosis. It is projected to favor the expansion of the global market by bringing advanced, precise and effective drugs and treatments.

Definite causes for the development of autoimmune diseases have not been identified. Thus, the emphasis is on the early diagnosis of the disease. Increasing awareness coupled with large-scale prevalence is likely to aid the proliferation of the Autoimmune Disease Treatment Market Overview in the foreseeable future.

Expenditures for the treatment of these diseases are on the rise and is poised to exhibit a similar trend in the forthcoming years. As per the National Institutes of Health (NIH), the U.S., the healthcare expenditure for autoimmune diseases has reached half of that of the cancer expenditure. Furthermore, the introduction of favorable policies for insurance reimbursements are anticipated to augment the market over the next couple of years. However, factors such as side effects, counterfeit drugs, and expensiveness of the treatment are forecasted to check the expansion of the autoimmune disease treatment market across the review period.

Competitive Dashboard:

Autoimmune Disease Treatment MarketPlayers are Abbott Laboratories, Genentech Inc., Bayer Schering Pharma AG, Amgen Inc., Biogen Idec Inc., Chugai Pharmaceutical Co. Ltd., Danaher, Bio-Rad, Elan Corporation Plc, F. Hoffmann-La Roche AG, GlaxoSmithKline Plc, HYCOR Biomedical, Eli Lilly and Company, Johnson & Johnson Inc., Siemens, Squibb Company, Merck & Co. Inc., and Thermo Fisher Scientific.

Market Segmentation

By disease type, the global autoimmune disease treatment market has been segmented into localized, and systemic. The localized segment is further sub-segmented into multiple sclerosis, inflammatory bowel disease, diabetes, and other. The systemic segment is sub-segmented into rheumatoid arthritis, psoriasis, lupus, and others.

By diagnosis, the autoimmune disease treatment market outlook has been segmented into ELISA, dot blot, line blot, agglutination, double immune diffusion, western blotting, multiplex immunoassay, and others.

By therapeutic products, the market has been segmented into drugs and therapeutic and monitoring equipment. The drugs segment is further sub-segmented into biologics, immunosuppressant, anti-inflammatory drugs, corticosteroids, and non-steroidal anti-inflammatory drugs.

By distribution channel, the autoimmune disease treatment market is segmented into hospitals & clinics, diagnostic centers, drug stores, pharmacies, and others.

Regional Analysis

The autoimmune disease treatment market report spans across Asia Pacific, Americas, Europe, and the Middle East & Africa. Americas signifies a huge potential for growth owing to increasing patient population. In addition, the increase witnessed in the expenditures associated with medical facilities is prognosticated to favor the expansion of the market over the next couple of years. The region has been estimated to gain control over the largest share of market in the forthcoming years.

The government of Europe has extended firm support in favor of research & development in the healthcare sector. This, in turn, is likely to pave the way for the growth of the in the region. It is expected to place the region on the second spot globally over 2023.

Asia Pacific has unleashed immense opportunities in the market through rapid developments witnessed in the healthcare sector. The population has also created a positive influence on the growth of the market by increasing its healthcare expenditures.

Related reports-

Heart Transplant Market Research Report - Global Forecast till 2030

Bladder Cancer Market Research Report - Forecast to 2030

CBD Hemp Oil Market Research Report – Forecast to 2030

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), & Consulting Services. MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients.

Contact us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street, 5Th Floor,

New York, New York 10013

United States of America

+1 628 258 0071

Email: sales@marketresearchfuture.com

[delvenservices]

In Vitro Toxicology Market Competitive Landscape

In Vitro Toxicology Market, By Product (Assay (Western Blot, Tissue Culture), Equipment, Assay Reagent, Software), Toxicity Endpoints (ADME, Skin Irritation, Corrosion), Industry (Pharmaceutical, Cosmetics) and Geography (North America, Europe, Asia-Pacific, Middle East and Africa and South America)

Market Overview

Global in Vitro Toxicology market is anticipated to reach USD 10.8 billion in 2021 growing at a CAGR of 11.5% during the forecasting period, 2021-2028.

In vitro toxicology is a set of technique used to study and identify the effect of various toxins on bacteria and other organisms. As a result of these testing only a drug or chemical is verified for human use. There are various methods like cytotoxicity, toxicokinetics etc. It also leads to develop a dose response relationship.

With an increased research in the sector along with the recent opposition to animal testing are some of the factors that have supported long-term expansion for In Vitro Toxicology industry.

To Understand Business Strategies, Request for a Sample Report at: https://www.delvens.com/get-free-sample/in-vitro-toxicology-market-trends-forecast-till-2028

Key Findings

Global In Vitro Toxicology market is segmented into Product, Toxicity Endpoints, Industry and geography.

Product segment is segmented into Assay (Western Blot, Tissue Culture), Equipment, Assay Reagent, and Software

Toxicity Endpoints segment is segmented into ADME, Skin Irritation, Corrosion

Industry segment is segmented into Pharmaceutical, Cosmetics

Geographically, global In Vitro Toxicology market is sub segmented into North America, Europe, Asia-Pacific, Middle East and Africa and South America and insights are provided for each region and major countries within the regions

To Grow Your Business Revenue, Make an Inquiry Before Buying at: https://www.delvens.com/Inquire-before-buying/in-vitro-toxicology-market-trends-forecast-till-2028

Competitive Landscape

Key players in global In Vitro Toxicology market are

Thermo Fisher Scientific Inc. (US),

Eurofins Scientific SE (Luxembourg),

Covance (US),

Bio-Rad Laboratories, Inc. (US),

GE Healthcare (US),

Merck KGaA (Germany),

Charles River Laboratories International, Inc. (US),

 Catalent, Inc. (US),

Cyprotex (UK),

SGS S.A. (Switzerland),

BioRad Laboratories,

QIAGEN N.V. (Germany),

Promega Corporation (US),

Gentronix Limited (UK),

BioIVT (US),

MB Research Laboratories (US),

Creative Biolabs(US),

GVK Biosciences Private Limited (India),

Shanghai Medicon Inc (China),

Creative Biorray (US)

Insphero (Switzerland)

Reasons to Acquire

Increase your understanding of the market for identifying the best and suitable strategies and decisions on the basis of sales or revenue fluctuations in terms of volume and value, distribution chain analysis, market trends and factors

Gain authentic and granular data access for In Vitro Toxicology market so as to understand the trends and the factors involved behind changing market situations

Qualitative and quantitative data utilization to discover arrays of future growth from the market trends of leaders to market visionaries and then recognize the significant areas to compete in the future

In-depth analysis of the changing trends of the market by visualizing the historic and forecast year growth patterns

Direct Purchase of Research Report at: https://www.delvens.com/checkout/in-vitro-toxicology-market-trends-forecast-till-2028

The In Vitro Toxicology Market report answers a number of crucial questions, including:

Which companies dominate the In Vitro Toxicology Market?

What current trends will influence the market over the next few years?

 What are the market's opportunities, obstacles, and driving forces?

What predictions for the future can help with strategic decision-making?

What advantages does market research offer businesses?

Which particular market segments should industry players focus on in order to take advantage of the most recent technical advancements?

What is the anticipated growth rate for the market economy globally?

Read More:

About Us:

Delvens is a strategic advisory and consulting company headquartered in New Delhi, India. The company holds expertise in providing syndicated research reports, customized research reports and consulting services. Delvens qualitative and quantitative data is highly utilized by each level from niche to major markets, serving more than 1K prominent companies by assuring to provide the information on country, regional and global business environment. We have a database for more than 45 industries in more than 115+ major countries globally.

Delvens database assists the clients by providing in-depth information in crucial business decisions. Delvens offers significant facts and figures across various industries namely Healthcare, IT & Telecom, Chemicals & Materials, Semiconductor & Electronics, Energy, Pharmaceutical, Consumer Goods & Services, Food & Beverages. Our company provides an exhaustive and comprehensive understanding of the business environment.

Contact Us:

UNIT NO. 2126, TOWER B,

21ST FLOOR ALPHATHUM

SECTOR 90 NOIDA 201305, IN

+44-20-8638-5055

SALES@DELVENS.COM

[myblogscmi]

Global Western Blotting Market Is Estimated To Witness High Growth Owing To Increasing Emphasis On Proteomics Research

The global Western Blotting Market is estimated to be valued at USD 759.5 million in 2023 and is expected to exhibit a CAGR of 6.8% over the forecast period 2023-2030, as highlighted in a new report published by Coherent Market Insights. A) Market Overview: Western blotting is a widely used laboratory technique that enables the detection and analysis of specific proteins in complex samples. This technique involves the separation of proteins based on their size using gel electrophoresis and subsequent transfer to a membrane. The membrane is then probed with specific antibodies to detect the protein of interest. Western blotting provides researchers with valuable information about protein expression, post-translational modifications, and protein-protein interactions. The need for Western blotting products arises from the increasing emphasis on proteomics research. Proteomics plays a crucial role in understanding the molecular mechanisms underlying various diseases and identifying potential drug targets. Western blotting is an essential tool in proteomics research as it allows researchers to study the expression, localization, and interaction of proteins, enabling a deeper understanding of cellular processes. B) Market Key Trends: One key trend driving the growth of the Western Blotting Market is the increasing adoption of personalized medicine. Personalized medicine aims to provide tailored treatment options based on an individual's genetic makeup, biomarker expression, and disease characteristics. Western blotting is instrumental in biomarker discovery and validation, which are crucial steps in developing personalized medicine approaches. By accurately identifying disease-specific biomarkers, Western blotting helps in stratifying patients, selecting optimal treatment options, and monitoring treatment response. For example, the HER2/neu protein is an important biomarker in breast cancer. Western blotting allows the detection and quantification of HER2/neu protein levels, aiding in the selection of appropriate therapy for breast cancer patients. D) Key Takeaways: - The global Western Blotting Market is expected to witness high growth, exhibiting a CAGR of 6.8% over the forecast period. This growth can be attributed to increasing emphasis on proteomics research and personalized medicine. - North America is expected to dominate the Western blotting market due to factors such as the presence of well-established research infrastructure, favorable government initiatives, and a high prevalence of chronic diseases. - Thermo Fisher Scientific, Inc., GE HealthCare, F. Hoffmann-La Roche Ltd, Merck KGaA, and Bio-Rad Laboratories, Inc. are some of the key players operating in the global Western blotting market. These companies focus on developing technologically advanced products, strategic collaborations, and mergers and acquisitions to strengthen their market position. In conclusion, the Western blotting market is experiencing significant growth due to the increasing demand for proteomics research and personalized medicine. Technological advancements and favorable government initiatives are expected to drive market growth further. Key players in the market are actively investing in research and development to introduce innovative products and strengthen their market presence.

[tamanna31]

Blood Screening Market 2023- Business Planning Research and Resources, Revenue, and Forecasts 2030

Blood Screening Market Size & Trends

The global blood screening market size was valued at USD 2.76 billion in 2022 and is anticipated to grow at a compound annual growth rate (CAGR) of 11.7% from 2023 to 2030. 

Blood screening is a process in which donated blood is screened for infectious diseases such as HBV, HCV, HIV1, and HIV2. The high growth of this market is attributed to rising blood donations, an increase in the incidence of infectious diseases, and government initiatives. According to World Health Organization (WHO), 118.54 million blood donations are collected yearly. In the U.S., 6.8 million individuals donate blood annually, and 13.6 million units of red blood cells and whole blood are collected annually.

Gather more insights about the market drivers, restrains and growth of the Blood Screening Market

The market is primarily driven by the rise in the rate of disorders such as HIV, diphtheria, measles and chronic diseases such as hemophilia, cancer, and other blood-related disorders. Blood-based diagnostics are used to diagnose a wide range of diseases, including infectious diseases, cancer, and cardiovascular diseases. Serology tests detect the presence of antibodies to a specific disease-causing organism. These tests diagnose various infectious diseases, including HIV, hepatitis B, and syphilis. Molecular tests detect the presence of DNA or RNA from a specific disease-causing organism. These tests are more sensitive than serology tests and can be used to diagnose diseases at an earlier stage. Biochemical tests measure the levels of certain substances in the blood. These tests can diagnose a wide range of diseases, including diabetes, kidney disease, and liver disease.

The COVID-19 pandemic had a significant impact on the market. Although respiratory droplets are the primary means of COVID-19 virus transmission, research has shown that viral RNA may be discovered in blood samples, supporting blood screening for COVID-19 identification, hence driving the market significantly. 

Blood Screening Market Segmentation

Grand View Research has segmented the global blood screening market based on technology, product, and region:

Technology Outlook (Revenue, USD Million, 2018 - 2030)

Nucleic Acid Amplification Test (NAT)

ELISA

Chemiluminescence Immunoassay (CLIA) and Enzyme Immunoassay (EIA)

Next Generation Sequencing

Western Blotting

Product Outlook (Revenue, USD Million, 2018 - 2030)

Reagent

Instrument

Regional Outlook (Revenue, USD Million, 2018 - 2030)

North America

US

Canada

Europe

UK

Germany

France

Italy

Spain

Sweden

Norway

Denmark

Asia Pacific

Japan

China

India

Australia

Thailand

South Korea

Latin America

Brazil

Mexico

Argentina

Middle East and Africa

Saudi Arabia

South Africa

UAE

Kuwait

Browse through Grand View Research's Medical Devices Industry Research Reports.

The global embolic protection devices market size was valued at USD 612.9 million in 2023 and is projected to grow at a CAGR of 8.7% from 2024 to 2030. 

The global covered stent market size was estimated at USD 1.13 billion in 2023 and is projected to grow at a CAGR of 4.1% from 2024 to 2030. 

Key Companies & Market Share Insights

Product launches, approvals, strategic acquisitions, and innovations are just a few of the important business strategies used by market participants to maintain and grow their global reach.

For instance, in March 2023, Abbott received U.S Food and Drug Administration (FDA) clearance for a laboratory traumatic brain injury blood test, the first commercially available lab-based test for the assessment of mild traumatic brain injuries (TBIs), commonly referred to as concussions, which will be made widely available to hospitals across the U.S. This test, which is powered by Abbott’s Alinity i laboratory tool, will enable clinicians to evaluate individuals with mild traumatic brain injuries in a timely manner.

Furthermore, in May 2023, Siemens Healthcare introduced Atellica HEMA 570 and 580 next-generation hematology analyzers, which have user-friendly interfaces and can be connected to multiple analyzers to remove workflow barriers and provide high throughput time.

Key Blood Screening Companies:

Abbott

Danaher Corporation (Beckman Coulter)

Becton Dickinson and Company

Bio-Rad Laboratories, Inc.

Hoffman-La Roche Ltd.

Grifols, S.A.

Ortho-Clinical Diagnostics, Inc.

Siemens Healthcare GmbH

Thermo Fisher Scientific, Inc.

SOFINA s.a (Biomerieux)

Order a free sample PDF of the Blood Screening Market Intelligence Study, published by Grand View Research. 

[market-insider]

Transfer Membranes in Life Sciences Research: Market Analysis and Growth Patterns

The global transfer membrane market size is estimated to reach USD 554.4 million by 2030. Transfer membranes are used for transferring nucleic acids or proteins in blotting techniques such as Western blotting, Southern blotting, Northern blotting, etc. The growing applications of these techniques in gene mapping, DNA fingerprinting, proteomic analysis, etc. are increasing the utility of transfer membranes in the life sciences research industry globally.

Gain deeper insights on the market and receive your free copy with TOC now @: Transfer Membrane Market Report

Moreover, the demand for blotting techniques is growing substantially for the early detection of target diseases and causative agents. These techniques offer high sensitivity and specificity which boosts the adoption of transfer membranes for several diagnostics purposes. Hence, the growing demand for blotting membranes for detecting HIV infection, bovine spongiform encephalopathy, feline immunodeficiency virus infection, HBV infection, etc. is expected to boost the market growth. Similarly, the rising focus and rapid advancements in the development of novel therapies for the treatment of such disorders is anticipated to drive the market growth.

Furthermore, techniques such as Southern blotting are used for the identification of specific DNA sequences in a DNA sample and hence have applications in the recombinant DNA technology where they are used for the isolation of specific DNA fragments. It is also used in academic research studies aimed at identifying mutations and gene rearrangements to better understand neonatal and genetic diseases. Such widespread applications of the technique have led to an established market presence of transfer membranes which can positively affect the market growth in the near future.

[healthcaremarketfmi]

Catheter-Directed Thrombolysis Market Key Drivers and Restraints, Opportunities, Industry Share & Trend Analysis Report to 2032

The global catheter-directed thrombolysis market is expected to be worth US$ 432.0 million in 2022, rising at a 5.9% CAGR to be worth US$ 814.0 million by 2032.

Catheter-directed Thrombolysis Infection Market: Drivers and Restraints

The primary factor driving the growth of catheter-directed thrombolysis market is increasing the prevalence of stroke, pulmonary embolism and deep vein thrombosis around the globe. Besides that, the rising incidences of obesity along increasing geriatric population will propel the growth of catheter-directed thrombolysis market.

Moreover, the availability of emergency medical services and favourable health insurance coverage will also upsurge the growth of catheter-directed thrombolysis market. The scarcity of high health infrastructure in low economic countries will restrain the growth of catheter-directed thrombolysis market over the forecast period. Furthermore, a minor risk associated with the catheter-directed thrombolysis procedure will also restrain the growth of this market to some extent.

Thrombolysis is the therapeutic therapy to treat the clots in blot vessel and improve the blood flow to prevent the damage of tissue and organs. Thrombolysis can be done by injection of clot-busting drugs through an intravenous (IV) line or through a catheter which delivers the drugs directly to the blocking sites. Catheter-directed thrombolysis is a minimal invasive treatment which resolves the issue of clotted blood in the blood vessel. When the blood in the body has improper flow, it gets started to coagulate, which results the formation of semi-solid gel or clouting of blood.

The blood clot may continue to grow within the blood vessel and blocks the blood flow within that blood vessel, this may cause the damage of tissue or organ.  The equipment of catheter-directed thrombolysis includes an x-ray camera, catheter, special medications and a medical device is used to dissolve the blood clots.  Along with x-ray camera and catheter, this equipment consists of a radiographic table, one or two x-ray tubes and a monitor to visualize the procedure.

The x-ray imaging is used for guiding the medication to the site of the blood clot. X-ray machine produces the video of entire procedure which may visualize on a monitor. A catheter used during the thrombolysis, long, thin and hollow plastic tube. These catheters are designed in such way that medication can be easily delivered to the blood clotted site. Some other devices are also used with equipment during the procedure, such as ultrasound machine and other devices to monitor the heartbeat and blood pressure.

Catheter-directed Thrombolysis Market: Key Players 

Examples of some of the market participants in Catheter-directed Thrombolysis market identified across the value chain include Angio Dynamics, Inc., Boston Scientific Corporation, iVascular SLU, Straub Medical AG and others.

The research report presents a comprehensive assessment of the market and contains thoughtful insights, facts, historical data, and statistically supported and industry-validated market data. It also contains projections using a suitable set of assumptions and methodologies. The research report provides analysis and information according to market segments such as geographies, application, and industry.

For More Information: https://www.futuremarketinsights.com/reports/catheter-directed-thrombolysis-market

The report covers exhaustive analysis on:

Market Segments

Market Dynamics

Market Size

Current Trends/Issues/Challenges

Competition & Companies involved

Value Chain

The regional analysis includes:

North America (U.S., Canada)

Latin America (Mexico. Brazil)

Western Europe (Germany, Italy, France, U.K, Spain, Nordic countries, Belgium, Netherlands, Luxembourg)

Eastern Europe (Poland, Russia)

Asia-Pacific (China, India, ASEAN, Australia & New Zealand)

Japan

The Middle East and Africa (GCC, S. Africa, N. Africa)

The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides in-depth analysis of parent market trends, macroeconomic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.

Catheter-directed Thrombolysis Market: Segmentation

The global Catheter-directed Thrombolysis market is classified on the basis of delivery mode, indication, end user and geographic region.

Based on delivery mode, Catheter-directed Thrombolysis market is segmented into following:

Directly delivery to blood clot

Positioning medical device at clot site

[the-rachana]

Blood Screening Market Size (2022-2030) Industry Trends, Growth, Challenges, and Forecast: Growth Plus Reports

The global blood screening market is expected to develop considerably during the forecast period. The growth can be due to various factors such as higher blood donation rates, the prevalence of chronic illnesses and infectious diseases, and expanding economies. Other market drivers include the rapid development of new technologies and the introduction of enhanced products. Another beneficial factor in the market is the increase in healthcare initiatives or investments from public and private organizations.

The blood screening market was valued at US$ 2.3 billion in 2021. The market is expected to witness a CAGR of 8.1% from 2022 to 2030.  

Growing chronic illness/disease occurrences also contribute to market expansion. An increase in such incidences is a prime cause of the rise in fatalities. The risk factors include poor eating habits, physical inactivity, and use of cigarettes/tobacco and alcohol. According to the WHO (World Health Organization) report for 2021, nearly 17.9 million people die every year due to chronic diseases such as cancers (9.3 million), respiratory diseases (4.1 million), and diabetes (1.5 million). Thus, these factors encourage the growth of the market globally.

Download Sample PDF Brochure: https://growthplusreports.com/inquiry/request-sample/blood-screening-market/7907

Key players:

·        Ortho-Clinical Diagnostics Inc.

·        Thermo Fisher Scientific Inc.

·        Abbott Laboratories

·        F. Hoffmann-La Roche AG

·        Grifols S.A.

·        Quotient Technology Inc.

·        Bio-Rad Laboratories Inc.

·        Becton, Dickinson and Company

·        Danaher Corporation (Beckman Coulter)

·        Siemens Healthineers

By Technology:

·        ELISA

·        Western Blot

·        RT-PCR

·        Rapid Test

·        Nucleic Acid Amplification

By Product:

·        Software

·        Instrument

·        Reagent & Kits

Regional Analysis-

·        The Asia-Pacific market is anticipated to grow at a higher CAGR during the forecast period.

·        Major factors contributing to the growth of Blood Screening market in this region include the rising incidence of chronic infectious diseases, rising awareness regarding growing applications of Blood Screening, and increasing research activities in the field of Blood Screening.

·        The emergence of local players and new product launches has also played a critical role in boosting the Blood Screening market in this region.

Key Questions Answered in the Report Include:

(1) This report gives all the information about the industry analysis, revenue, and overview, of this market.

(2) What will be the rate of increase in market size and growth rate by the end of the forecast period?

(3) What are the major global Blood Screening Market trends influencing the development of the market?

(4) What are the vital results of SWOT analysis of the major players operating in the Blood Screening Market?

(5) What are the potential growth opportunities and threats faced by Major competitors in the market?

Browse the full report now: https://growthplusreports.com/report/blood-screening-market/7907

About Us:

Growth Plus Reports is part of GRG Health, a global healthcare knowledge service company. We are proud members of EPhMRA (European Pharmaceutical Marketing Research Association).

Growth Plus portfolio of services draws on our core capabilities of secondary & primary research, market modelling & forecasting, benchmarking, analysis, and strategy formulation to help clients create scalable, ground-breaking solutions that prepare them for future growth and success.

We were awarded by the prestigious CEO Magazine as "Most Innovative Healthcare Market Research Company in 2020.

[research--blog]

Autoimmune Disease Diagnostics Market Worth $7.53 Billion by 2029

According to a new market research report titled, ‘Autoimmune Disease Diagnostics Market by Product (Reagents, Kits, Assays, Instruments), Test Type (ANA, CRP, ESR, Rheumatoid Factor, Routine Test), Disease Type (Systemic, Localized), End User (Hospital, Diagnostic Lab, Research) – Global Forecast to 2029,’ published by Meticulous Research®, the autoimmune disease diagnostics market is expected to reach $7.53 billion by 2029, at a CAGR of 6.5% from 2022 to 2029.

Download Free Report Sample Now @ https://www.meticulousresearch.com/download-sample-report/cp_id=5405

Autoimmune diseases occur when the immune system attacks healthy cells and tissues. The trigger to these attacks can be genetic mutations, microorganisms, viruses, drugs, and environmental factors. The early diagnosis of these autoimmune diseases is necessary for an effective course of treatment or management. Autoimmune diseases can be systemic, affecting multiple organs or systems, or specific, affecting a single organ. Several tests such as western blot, antinuclear antibody, C-reactive protein (CRP), erythrocyte sedimentation rate (ESR), rheumatoid factor, immunoassays, routine blood tests, immunohistochemistry (IHC), and flow cytometry are used for diagnosing autoimmune diseases.

Increasing Prevalence of Autoimmune Diseases Driving the Growth of Autoimmune Disease Diagnostics market

There are more than 80 autoimmune diseases in which the immune system of a patient attacks its own body. The tests for autoimmune prove crucial for the early detection of these diseases. The early diagnosis of autoimmune diseases is also crucial to reduce the financial burden. For instance, according to the American Autoimmune Related Disease Association, around 50 million people in the U.S. suffer from autoimmune diseases and incur USD 86 billion per year in managing their conditions. Autoimmune disease testing is expected to increase due to the increasing prevalence of these diseases. For instance, according to the Lancet Diabetes & Endocrinology, in 2021, around 8.4 million people were affected with type-1 diabetes (one of the most common autoimmune diseases) globally. This number is estimated to increase to 13.5–17.4 million people by 2040. Additionally, around 4% of the global population suffers from one or more autoimmune diseases.

Speak to our Analysts to Understand the Impact of COVID-19 on Your Business: https://www.meticulousresearch.com/speak-to-analyst/cp_id=5405

The autoimmune disease diagnostics market is segmented based on Product Category (Reagents, Assays, & Kits and Instruments), Test Type (Antinuclear Antibodies (ANA), Western Blot, Immunoassays, C-reactive Protein (CRP), Erythrocyte Sedimentation Rate (ESR)), Rheumatoid Factor, Immunoglobulins, Routine Blood Tests, Immunohistochemistry (IHC), Flow Cytometry, and Other Test Types), Disease Type (Systemic Autoimmune Diseases and Organ-specific Autoimmune Diseases), End Users (Hospitals & Clinics, Diagnostics Laboratories, Academic & Research Institutes), and Geography (North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa). The study also evaluates industry competitors and analyzes the market at the global and regional levels.

Based on the product category, the reagents, kits, and assays segment is slated to register the higher CAGR during the forecast period. The frequent use of reagents for diagnosing diseases and growing awareness and testing capabilities are the major factors driving the growth of this segment.

Based on test type, the antinuclear antibody test segment is slated to register the fastest growth rate during the forecast period. The antibody responsible for autoimmune diseases are formed in the blood much earlier than the onset of the actual disease in an individual; this enables the early diagnosis of the disease, which helps to reduce morbidity and mortality due to the disease. The antinuclear antibodies test is simple and has higher accuracy than other tests. Therefore, the increasing prevalence of autoimmune diseases, the need for early disease diagnosis, and the ease of use and low turnaround time of ANA test drive the segment’s growth.

Quick Buy – Autoimmune Disease Diagnostics Market- Global Opportunity Analysis And Industry Forecast (2022-2029), Research Report: https://www.meticulousresearch.com/Checkout/84306372

Based on disease type, the systemic segment is slated to register the highest CAGR during the forecast period. Systemic autoimmune diseases affect multiple organs or systems. The rising prevalence of systemic autoimmune diseases has led companies operating in the autoimmune disease diagnostics market to launch tests for diagnosing systemic autoimmune diseases. For instance, in June 2022, Thermo Fisher Scientific Inc. (U.S.) launched EliA RNA Pol III and EliA Rib-P tests cleared by the U.S. FDA. These tests are used to diagnose Systemic Sclerosis (SSS) and Systemic Lupus Erythematosus (SLE). Thus, the increasing number of companies launching tests for systemic autoimmune diseases drives this segment’s growth.

Based on end user, in 2022, the hospitals & clinics segment is expected to account for the largest share of the market. The large market share of this segment is attributed to the high adoption rate of testing technologies by hospitals and the rising expansion of existing testing capabilities to provide cost- and time-efficient tests.

Based on geography, in 2022, North America is expected to account for the largest share of the autoimmune disease diagnostics market, followed by Europe and Asia-Pacific. North America’s major market share is attributed to factors such as high healthcare expenditure, high prevalence of autoimmune diseases, increased awareness among patients regarding autoimmune diseases, and increased funding and investments towards R&D of autoimmune diseases.

The report includes an extensive assessment of product portfolios, geography, and key growth strategies adopted by leading market participants between 2020 and 2022.

Some of the key players operating in the autoimmune disease diagnostics market are Thermo Fisher Scientific Inc. (U.S.), Bio-Rad Laboratories, Inc. (U.S.), Beckman Coulter, Inc. (U.S.), Abbott Laboratories (U.S.), Myriad Genetics, Inc. (U.S.), EUROIMMUN Medizinische Labordiagnostika AG (Germany), F. Hoffmann-La Roche Ltd (Switzerland), Siemens Healthineers AG (Germany), Grifols, S.A. (Spain), and Creative Diagnostics (U.S.).

To gain more insights into the market with a detailed table of content and figures, click here: https://www.meticulousresearch.com/product/autoimmune-disease-diagnostics-market-5405

Scope of the Report

Autoimmune Disease Diagnostics Market, by Product Type

Reagents, Assays, and Kits

Instruments

Autoimmune Disease Diagnostics market, by Test Type

Antinuclear Antibodies (ANA) Test

Rheumatoid Factor Test

Immunoglobulins Test

Routine Blood Tests

C-reactive Protein (CRP) Test

Erythrocyte Sedimentation Rate (ESR) Test

Other Test Types

Note: Other test types include Anti-double stranded DNA, Extractable nuclear antigen, Anti-signal recognition particle tests, Ferritin, and Anti-cyclic Citrullinated Peptide (Anti-CCP) Antibodies.

Autoimmune Disease Diagnostics Market, by Disease Type

Systemic Autoimmune Diseases

Organ-specific Autoimmune Diseases

Autoimmune Disease Diagnostics market, by End User

Hospitals & Clinics

Diagnostic Laboratories

Academic & Research Institutes

Autoimmune Disease Diagnostics Market, by Geography

North America

U.S.

Canada

Europe

Germany

France

U.K.

Italy

Spain

Rest of Europe (RoE)

Asia-Pacific (APAC)

Japan

China

India

Rest of APAC (RoAPAC)

Latin America (LATAM)

Brazil

Mexico

Rest of Latin America (RoLATAM)

Middle East & Africa

Download Free Report Sample Now @ https://www.meticulousresearch.com/download-sample-report/cp_id=5405